← Leaderboards
John Curtin
New York University School Of Medicine
$59,043
Attributed
$59,043
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $35.4K · FY2005–09$50K$37.5K$25K$12.5K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$59,043 · 3
By mechanism
P30$55,518 · 1
M01$3,525 · 2
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Franco M Muggia$5,360,861
- Agnel Sfeir$14,727,073
- Iman Osman$8,470,073
- Anne Zeleniuch-Jacquotte$14,853,206
- Howard S Hochster$9,390,994
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical TrialsInstitutionFemaleHuman Therapy EvaluationInstitutesClinical ProtocolsConduct Clinical TrialsDiagnosticEnsureHuman SubjectAuthorityCombination ChemotherapyCaringCommittee MembershipCancer CareData IntegrityDesignDrug Screening /EvaluationDoctor Of MedicineBaseEnrollmentFundingInvestigation
Grant awards (5)
Protocol Review and Monitoring$35,395
P30 · FY2009 · CA · contact PI
Protocol Review and Monitoring$20,123
P30 · FY2008 · CA · contact PI
PHASE III TRIAL OF VARIOUS CHEMOTHERAPY REGIMENS IN OVARIAN/PERITONEAL CA$477
M01 · FY2005 · RR
Phase III Trial of Various Chemotherapy Regimens in Ovarian/Peritoneal CA$2,540
M01 · FY2004 · RR
Irradiation &Cisplatin/Doxorubicin Plus or Minus Paclit$508
M01 · FY2004 · RR